Kindeva offers both cold-fill and pressure-fill aerosol capabilities for pressurized metered-dose inhalers (pMDIs), including next-generation propellants such as HFA-152a and HFO-1234ze. These systems support clinical to commercial scale production with integrated formulation, device and packaging capabilities.